Dr. Michael Yamashita, MD
Claim this profileUniversity of Manitoba
Studies Thoracic Aortic Disease
Studies Aortic Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
University Of Manitoba
St Boniface Hospital
Clinical Trials Michael Yamashita, MD is currently running
Hypothermia During Aortic Surgery
for undefined
Hypothermic circulatory arrest is an important surgical technique, allowing complex aortic surgeries to be performed safely. Hypothermic circulatory arrest provides protection to cerebral and visceral organs, but may result in longer cardiopulmonary bypass times during surgery, increased risks of bleeding, inflammation, and neuronal injury. To manage these consequences, a trend towards warmer core body temperatures during circulatory arrest has emerged. This trial will randomize patients to either mild (32°C) or moderate (26°C) hypothermia during aortic hemiarch surgery to determine if mild hypothermia reduces the length of cardiopulmonary bypass time and other key measures of morbidity and mortality.
Recruiting1 award N/A5 criteria
DOAC vs Warfarin as Blood Thinners After Heart Surgery
for undefined
The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Recruiting3 awards Phase 34 criteria
More about Michael Yamashita, MD
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Yamashita, MD has experience with
- Hypothermic Circulatory Arrest
- DOAC
- VKA
Breakdown of trials Michael Yamashita, MD has run
Thoracic Aortic Disease
Aortic Disease
Blood Thinners
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Yamashita, MD specialize in?
Michael Yamashita, MD focuses on Thoracic Aortic Disease and Aortic Disease. In particular, much of their work with Thoracic Aortic Disease has involved treating patients, or patients who are undergoing treatment.
Is Michael Yamashita, MD currently recruiting for clinical trials?
Yes, Michael Yamashita, MD is currently recruiting for 2 clinical trials in Winnipeg Manitoba. If you're interested in participating, you should apply.
Are there any treatments that Michael Yamashita, MD has studied deeply?
Yes, Michael Yamashita, MD has studied treatments such as Hypothermic circulatory arrest, DOAC, VKA.
What is the best way to schedule an appointment with Michael Yamashita, MD?
Apply for one of the trials that Michael Yamashita, MD is conducting.
What is the office address of Michael Yamashita, MD?
The office of Michael Yamashita, MD is located at: University of Manitoba, Winnipeg, Manitoba R2H 2A6 Canada. This is the address for their practice at the University of Manitoba.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.